Pubmed    Pubmed Central
uBio Home | uBioRSS

WebSearchLiteratureMolecularImages

 uBio  Web Results 1 - 10 of about 456451

Scientific:
   Zeus faber (San Pietro) 

Synonyms:
   Arrhyton tanyplectum (San Vincente Island Racer) 
   Batrachoseps gabrieli (San Gabriel Mountain slender salamander) 
   Batrachoseps incognitus (San Simeon Slender Salamander) 
   Cordia rickseckeri (San Bartolome) 
   Crotalaria pallida pallida (Sen (Hi)) 
   Cyprinodon pachycephalus (Cachorrito cabezon) 
   Halichoeres dispilus (Chameleon wrasse) 
   Lampris guttatus (kingfish) 
   Leptotyphlops columbi (San Salvador Blind Snake) 
   Microlophus bivittatus (San Cristobal Lava Lizard) 
   Ormosia coutinhoi (Buiussķ) 
   Pristis pectinata (smalltooth sawfish) 
   Uta palmeri (San Pedro Side-blotched Lizard) 
   Zeus faber (St. Peter's fish) 
   Zoothera margaretae (San Cristobal Thrush) 

Broader Terms:
   Passeriformes (perching birds) 
   San 
   Zoothera 
 
 
Latest Articles on San Pietro from uBioRSS
Ghosts of the coast: global extinction risk and conservation of sawfishes - Aquatic Conservation: Marine and Freshwater Ecosys...
Use of encounter data to model spatio‚Äźtemporal distribution patterns of e... - Aquatic Conservation: Marine and Freshwater Ecosys...


Zeus faber
NYPL Digital Gallery

External Resources:



1.  Myocardial Infarction Can Be Safely Excluded by High-sensitivity Troponin I Testing 3 Hours After Emergency Department Presentation.LinkIT
Peacock WF, Christenson R, Diercks DB, Fromm C, Headden GF, Hogan CJ, Kulstad EB, LoVecchio F, Nowak RM, Schrock JW, Singer AJ, Storrow AB, Straseski J, Wu AHB, Zelinski DP
Academic emergency medicine : official journal of the Society for Academic Emergency Medicine Acad Emerg Med Myocardial Infarction Can Be Safely Excluded by High-sensitivity Troponin I Testing 3 Hours After Emergency Department Presentation. 10.1111/acem.13922 The accuracy and speed by which acute myocardial infarction (AMI) is excluded are an important determinant of emergency department (ED) length of stay and resource utilization. While high-sensitivity troponin I (hsTnI) >99th percentile (upper reference level [URL]) represents a "rule-in" cutpoint, our purpose was to evaluate the ability of the Beckman Coulter hsTnI assay, using various level-of-quantification (LoQ) cutpoints, to rule out AMI within 3¬†hours of ED presentation in suspected acute coronary syndrome (ACS) patients. This multicenter evaluation enrolled adults with >5¬†minutes of ACS symptoms and an electrocardiogram obtained per standard care. Exclusions were ST-segment elevation or chronic hemodialysis. After informed consent was obtained, blood samples were collected in heparin at ED admission (baseline), ?1 to 3, ?3 to 6, and ?6 to 9¬†hours postadmission. Samples were processed and stored at -20¬įC within 1¬†hour and were tested at three independent clinical laboratories on an immunoassay system (DxI 800, Beckman Coulter). Analytic cutpoints were the URL of 17.9¬†ng/L and two LoQ cutpoints, defined as the 10 and 20% coefficient of variation (5.6 and 2.3¬†ng/L, respectively). A criterion standard MI diagnosis was adjudicated by an independent endpoint committee, blinded to hsTnI, and using the universal definition of MI. Of 1,049 patients meeting the entry criteria, and with baseline and 1- to 3-hour hsTnI results, 117 (11.2%) had an adjudicated final diagnosis of AMI. AMI patients were typically older, with more cardiovascular risk factors. Median (IQR) presentation time was 4 (1.6-16.0)¬†hours after symptom onset, although AMI patients presented ~0.5¬†hour earlier than non-AMI. Enrollment and first blood draw occurred at a mean of ~1¬†hour after arrival. To evaluate the assay's rule-out performance, patients with any hsTnI¬†>¬†URL were considered high risk and were excluded. The remaining population (n¬†=¬†829) was divided into four LoQ relative categories: both hsTnI¬†<¬†LoQ (Lo-Lo cohort); first hsTnI¬†<¬†LoQ and 2nd¬†>¬†LoQ (Lo-Hi cohort); first¬†>¬†LoQ and second¬†<¬†LoQ (Hi-Lo cohort); or both¬†>¬†LoQ (Hi-Hi cohort). In patients with any hsTnI result <20% CV LoQ (Groups 1-3), n¬†=¬†231 (23.9% ruled out), AMI negative predictive value (NPV)¬†was¬†100% (95% confidence interval [CI]¬†= 98.9% to 100%). In patients with any hsTnI below the 10% LoQ, n¬†=¬†611 (58% rule out), AMI NPV¬†was¬†100% (95% CI¬†= 99.5% to 100%). Of the Hi-Hi cohort (i.e., no hsTnI below the 10% LoQ, but both¬†<¬†URL), there were four AMI patients, NPV¬†was¬†98.2% (95% CI¬†= 95.4% to 99.3%), and sensitivity¬†was¬†96.6. Patients presenting >3¬†hours after the onset of suspected ACS symptoms, with at least two Beckman Coulter Access hsTnI¬†<¬†URL and at least one of which is below either the 10 or the 20% LoQ, had a 100% NPV for AMI. Two hsTnI values 1 to 3¬†hours apart with both¬†<¬†URL, but also >LoQ had inadequate sensitivity and NPV. ¬© 2020 The Authors. Academic Emergency Medicine published by Wiley Periodicals, Inc. on behalf of Society for Academic Emergency Medicine (SAEM). Peacock W Frank WF https://orcid.org/0000-0002-2730-6742 From the, Emergency Medicine, Baylor College of Medicine, Houston, TX. Christenson Robert R the, Department of Pathology, University of Maryland, Baltimore, MD. Diercks Deborah B DB the, Department of Emergency Medicine, UT Southwestern Medical Center, Dallas, TX. Fromm Christian C the, Department of Emergency Medicine, Einstein Healthcare Network, Philadelphia, PA. Headden Gary F GF the, Department of Emergency Medicine, Medical University of South Carolina, Charleston, SC. Hogan Christopher J CJ the, Department of Emergency Medicine, Virginia Commonwealth University, Richmond, VA. Kulstad Erik B EB the, Department of Emergency Medicine, UT Southwestern Medical Center, Dallas, TX. LoVecchio Frank F the, Department of Emergency Medicine, Banner Health, Phoenix, AZ. Nowak Richard M RM the, Department of Emergency Medicine, Henry Ford Health System, Detroit, MI. Schrock Jon W JW the, Department of Emergency Medicine, Case Western University, Cleveland, OH. Singer Adam J AJ the, Department of Emergency Medicine, Stonybrook University, Stonybrook, NY. Storrow Alan B AB https://orcid.org/0000-0002-2893-808X the, Department of Emergency Medicine, Vanderbilt University Medical Center, Nashville, TN. Straseski Joely J ARUP Laboratories, University of Utah School of Medicine, Salt Lake City, UT. Wu Alan H B AHB the, Department of Pathology, University of California, San Francisco, CA. Zelinski Daniel P DP and the, Emergency Department, Dublin Methodist Hospital, Dublin, OH. eng Journal Article 2020 03 27 United States Acad Emerg Med 9418450 1069-6563 IM 2019 10 07 2020 01 13 2020 01 16 2020 3 29 6 0 2020 3 29 6 0 2020 3 29 6 0 aheadofprint 32220124 10.1111/acem.13922 References, 2020</i></font><br><font color=#008000>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0<br></font></span><br>2.  <a href=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0 class=title>Frequency of food allergy in school-aged children in eight European countries - the EuroPrevall-iFAAM birth cohort.</a><a href=http://ubio.org/tools/linkit.php?map%5B%5D=all&link_type=2&url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0><img src=linkit.png border=0 title='LinkIT' alt='LinkIT'></a> <br><span class=j>Grabenhenrich L, Trendelenburg V, Bellach J, Y√ľrek S, Reich A, Fiandor A, Rivero D, Sigurdardottir ST, Clausen M, Papadopoulos NG, Xepapadaki P, Sprikkelman AB, Dontje B, Roberts G, Grimshaw K, Kowalski ML, Kurowski M, Dubakiene R, Rudzeviciene O, Fern√°ndez-Rivas M, Couch P, Versteeg SA, van Ree R, Mills E, Keil T, Beyer K<br><font color=gray><i>Allergy, 2020</i></font><br><font color=#008000>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0<br></font></span><br>3.  <a href=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0 class=title>Progressive Supranuclear Palsy and Statin Use.</a><a href=http://ubio.org/tools/linkit.php?map%5B%5D=all&link_type=2&url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0><img src=linkit.png border=0 title='LinkIT' alt='LinkIT'></a> <br><span class=j>Bayram E, Marras C, Standaert DG, Kluger BM, Bordelon YM, Shprecher DR, Litvan I,<br><font color=gray><i>Movement disorders : official journal of the Movement Disorder Society Mov. Disord. Progressive Supranuclear Palsy and Statin Use. 10.1002/mds.28038 Statins were proposed to be neuroprotective; however, the effects are unknown in progressive supranuclear palsy (PSP), a pure tauopathy. Data of 284 PSP cases and 284 age-matched, sex-matched, and race-matched controls were obtained from the environmental and genetic PSP (ENGENE-PSP) study. Cases were evaluated with the PSP Rating Scale, Unified Parkinson's Disease Rating Scale, Mattis Dementia Rating Scale, and Neuropsychiatric Inventory. Statin associations with PSP risk, onset age, and disease features were analyzed. Univariate models showed lower PSP risk for type 1 statin users (simvastatin, lovastatin, pravastatin). After adjusting for confounding variables, statin use and lower PSP risk association remained only at a trend level. For PSP cases, type 1 statins were associated with 1-year older onset age; type 2 statins (atorvastatin, rosuvastatin) were associated with the lower PSP Rating Scale and Unified Parkinson's Disease Rating Scale. Statins may have inverse associations with PSP risk and motor impairment. Randomized prospective studies are required to confirm this effect. ¬© 2020 International Parkinson and Movement Disorder Society. ¬© 2020 International Parkinson and Movement Disorder Society. Bayram Ece E https://orcid.org/0000-0002-6875-4242 Movement Disorders Center, Department of Neurosciences, University of California San Diego, San Diego, CA, USA. Marras Connie C Morto and Gloria Shulman Movement Disorders Centre and The Edmond J Safra Program in Parkinson's Research, Toronto Western Hospital, University of Toronto, Toronto, Ontario, Canada. Standaert David G DG https://orcid.org/0000-0003-2921-8348 Department of Neurology, University of Alabama at Birmingham, Birmingham, Alabama, USA. Kluger Benzi M BM Department of Neurology, University of Colorado, Aurora, Colorado, USA. Bordelon Yvette M YM Department of Neurology, University of California Los Angeles, California, USA. Shprecher David R DR Department of Neurology, University of Utah, Salt City, Utah, USA. Department of Neurology, University of Arizona, Phoenix, Arizona, USA. Litvan Irene I Movement Disorders Center, Department of Neurosciences, University of California San Diego, San Diego, CA, USA. and the ENGENE-PSP Consortium eng Journal Article 2020 03 27 United States Mov Disord 8610688 0885-3185 IM case-control progressive supranuclear palsy statins tauopathy 2019 11 26 2020 03 03 2020 03 05 2020 3 29 6 0 2020 3 29 6 0 2020 3 29 6 0 aheadofprint 32220093 10.1002/mds.28038 References, 2020</i></font><br><font color=#008000>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0<br></font></span><br>4.  <a href=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0 class=title>Oregano essential oil interactions with photogenerated singlet molecular oxygen.</a><a href=http://ubio.org/tools/linkit.php?map%5B%5D=all&link_type=2&url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0><img src=linkit.png border=0 title='LinkIT' alt='LinkIT'></a> <br><span class=j>Dimarco Palencia FCD, Mu√Īoz VA, Posadaz AC, Cifuente DA, Miskoski S, Ferrari GV, Garc√≠a NA, Monta√Īa MP<br><font color=gray><i>Photochemistry and photobiology, 2020</i></font><br><font color=#008000>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0<br></font></span><br>5.  <a href=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0 class=title>Expansile cribriform Gleason pattern 4 has histopathologic and molecular features of aggressiveness and greater risk of biochemical failure compared to glomerulation Gleason pattern 4.</a><a href=http://ubio.org/tools/linkit.php?map%5B%5D=all&link_type=2&url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0><img src=linkit.png border=0 title='LinkIT' alt='LinkIT'></a> <br><span class=j>Greenland NY, Cowan JE, Zhang L, Carroll PR, Chan E, Stohr BA, Simko JP<br><font color=gray><i>The Prostate Prostate Expansile cribriform Gleason pattern 4 has histopathologic and molecular features of aggressiveness and greater risk of biochemical failure compared to glomerulation Gleason pattern 4. 10.1002/pros.23977 Molecular testing of prostate cancer biopsies with Gleason pattern 4 suggests the expansile cribriform pattern is more aggressive than the glomerulation pattern. These two extreme patterns have not been compared at prostatectomy. We hypothesized that at prostatectomy the expansile cribriform pattern would be associated with histopathologic and molecular features of aggressiveness and with greater risk of biochemical recurrence (BCR) than the glomerulation pattern. In a retrospective cohort study, radical prostatectomy reports with expansile cribriform pattern or glomerulation pattern were analyzed for percentage of total pattern 4, extraprostatic extension (EPE), positive lymph nodes, seminal vesicle invasion (SVI), and intraductal carcinoma (IDC). Cases with pattern 5 or with both expansile cribriform and glomerulations patterns present were excluded. The electronic medical record was reviewed for BCR-free survival and for Decipher test results. Of 1020 radical prostatectomies from July 2015 to July 2018, 110 (11%) had either expansile cribriform or glomerulation pattern present. The expansile cribriform group was associated with more histopathologic features of aggressiveness, with higher average total percentage pattern 4 (43.7 vs 27.0, P?=?.002), a trend of greater extensive EPE (32.7% vs 17.2%, P?=?.06), a trend toward statistical significance of higher rate of SVI (11.5% vs 3.4%, P?=?.1), greater positive lymph nodes (9.6% vs 0%, P?=?.02), and a higher percentage of cases with or suspicious for IDC (23.1% vs 8.6%, P?=?.04). The risk of BCR was 4.4 (1.3-15.4) fold greater for the expansile cribriform group vs the glomerulations group (P?=?.02). For the 38 patients who underwent Decipher testing, the expansile cribriform group had a high-risk assay category mean score whereas the glomerulations group had an average risk assay category mean score (0.61 vs 0.47, P?=?.02). In a comparison of prostatectomy cases with expansile cribriform pattern to those with glomerulation pattern, the expansile cribriform pattern was associated with more histopathologic features of aggressiveness, greater risk of biochemical failure, and higher scores with a molecular classifier (Decipher) test. These findings underscore the importance of reporting the types of pattern 4 and supports the argument that men with expansile cribriform likely require more aggressive management. ¬© 2020 Wiley Periodicals, Inc. Greenland Nancy Y NY http://orcid.org/0000-0002-1783-1711 Department of Anatomic Pathology, University of California, San Francisco, California. Department of Pathology, Veterans Affairs Health Care System, San Francisco, California. Cowan Janet E JE Department of Urology, University of California, San Francisco, California. Zhang Li L Department of Epidemiology and Biostatistics, University of California, San Francisco, California. UCSF Helen Diller Comprehensive Cancer Center, University of California, San Francisco, California. Carroll Peter R PR Department of Urology, University of California, San Francisco, California. Chan Emily E Department of Anatomic Pathology, University of California, San Francisco, California. Stohr Bradley A BA Department of Anatomic Pathology, University of California, San Francisco, California. Simko Jeffry P JP Department of Anatomic Pathology, University of California, San Francisco, California. Department of Urology, University of California, San Francisco, California. eng UCSF Department of Anatomic Pathology Journal Article 2020 03 27 United States Prostate 8101368 0270-4137 IM Decipher expansile cribriform glomerulations large cribriform molecular testing 2020 01 22 2020 03 13 2020 03 18 2020 3 29 6 0 2020 3 29 6 0 2020 3 29 6 0 aheadofprint 32220141 10.1002/pros.23977 REFERENCES, 2020</i></font><br><font color=#008000>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0<br></font></span><br>6.  <a href=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0 class=title>Distinguishing Metastatic Triple Negative Breast Cancer from Non-metastatic Breast Cancer using SHG Imaging and Resonance Raman Spectroscopy.</a><a href=http://ubio.org/tools/linkit.php?map%5B%5D=all&link_type=2&url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0><img src=linkit.png border=0 title='LinkIT' alt='LinkIT'></a> <br><span class=j>Bendau E, Smith J, Zhang L, Ackerstaff E, Kruchevsky N, Wu B, Koutcher JA, Alfano R, Shi L<br><font color=gray><i>Journal of biophotonics, 2020</i></font><br><font color=#008000>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0<br></font></span><br>7.  <a href=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0 class=title>[Factores socioecon√≥micos y cl√≠nicos asociados con infecciones oportunistas en pacientes con HIV afiliados al sistema de salud].</a><a href=http://ubio.org/tools/linkit.php?map%5B%5D=all&link_type=2&url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0><img src=linkit.png border=0 title='LinkIT' alt='LinkIT'></a> <br><span class=j>Angulo-Ramos M, Merino-Soto C, Lopera MM, Lemos Y<br><font color=gray><i>Biomedica : revista del Instituto Nacional de Salud, 2020</i></font><br><font color=#008000>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0<br></font></span><br>8.  <a href=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0 class=title>[Efecto cl√≠nico y metab√≥lico de una intervenci√≥n multidisciplinaria en el marco de un programa de atenci√≥n integral para ni√Īos y adolescentes con obesidad].</a><a href=http://ubio.org/tools/linkit.php?map%5B%5D=all&link_type=2&url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0><img src=linkit.png border=0 title='LinkIT' alt='LinkIT'></a> <br><span class=j>Zuluaga NA, Osorno A, Lozano A, Villada O<br><font color=gray><i>Biomedica : revista del Instituto Nacional de Salud, 2020</i></font><br><font color=#008000>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0<br></font></span><br>9.  <a href=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0 class=title>Quality of life in patients with multiple sclerosis and their caregivers in Colombia: One-year follow-up.</a><a href=http://ubio.org/tools/linkit.php?map%5B%5D=all&link_type=2&url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0><img src=linkit.png border=0 title='LinkIT' alt='LinkIT'></a> <br><span class=j>Beltr√°n E, D√≠az D, D√≠az C, Zarco L<br><font color=gray><i>Biomedica : revista del Instituto Nacional de Salud, 2020</i></font><br><font color=#008000>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0<br></font></span><br>10.  <a href=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0 class=title>[Porfiria intermitente aguda: reporte de caso].</a><a href=http://ubio.org/tools/linkit.php?map%5B%5D=all&link_type=2&url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0><img src=linkit.png border=0 title='LinkIT' alt='LinkIT'></a> <br><span class=j>Bustos J, Vargas L, Quintero R<br><font color=gray><i>Biomedica : revista del Instituto Nacional de Salud, 2020</i></font><br><font color=#008000>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0<br></font></span><br><br><br><table cellspacing=0 cellpadding=0 align=center><tr valign=bottom><td align=center><img src=p.png border=0></td><td align=center><img src=o_red.png border=0></td><td align=center><a href=http://ubio.org/portal/index.php?search=San+Pietro&category=l&client=pubmed&startPage=2><img src=o_yellow.png border=0></a></td><td align=center><a href=http://ubio.org/portal/index.php?search=San+Pietro&category=l&client=pubmed&startPage=3><img src=o_yellow.png border=0></a></td><td align=center><a href=http://ubio.org/portal/index.php?search=San+Pietro&category=l&client=pubmed&startPage=4><img src=o_yellow.png border=0></a></td><td align=center><a href=http://ubio.org/portal/index.php?search=San+Pietro&category=l&client=pubmed&startPage=5><img src=o_yellow.png border=0></a></td><td align=center><a href=http://ubio.org/portal/index.php?search=San+Pietro&category=l&client=pubmed&startPage=6><img src=o_yellow.png border=0></a></td><td align=center><a href=http://ubio.org/portal/index.php?search=San+Pietro&category=l&client=pubmed&startPage=7><img src=o_yellow.png border=0></a></td><td align=center><a href=http://ubio.org/portal/index.php?search=San+Pietro&category=l&client=pubmed&startPage=8><img src=o_yellow.png border=0></a></td><td align=center><a href=http://ubio.org/portal/index.php?search=San+Pietro&category=l&client=pubmed&startPage=9><img src=o_yellow.png border=0></a></td><td align=center><a href=http://ubio.org/portal/index.php?search=San+Pietro&category=l&client=pubmed&startPage=10><img src=o_yellow.png border=0></a></td><td align=center><a href=http://ubio.org/portal/index.php?search=San+Pietro&category=l&client=pubmed&startPage=2><img src=rtal.png border=0></a></td></tr><td align=center></td><td align=center>1</td><td align=center><a href=http://ubio.org/portal/index.php?search=San+Pietro&category=l&client=pubmed&startPage=2>2</a></td><td align=center><a href=http://ubio.org/portal/index.php?search=San+Pietro&category=l&client=pubmed&startPage=3>3</a></td><td align=center><a href=http://ubio.org/portal/index.php?search=San+Pietro&category=l&client=pubmed&startPage=4>4</a></td><td align=center><a href=http://ubio.org/portal/index.php?search=San+Pietro&category=l&client=pubmed&startPage=5>5</a></td><td align=center><a href=http://ubio.org/portal/index.php?search=San+Pietro&category=l&client=pubmed&startPage=6>6</a></td><td align=center><a href=http://ubio.org/portal/index.php?search=San+Pietro&category=l&client=pubmed&startPage=7>7</a></td><td align=center><a href=http://ubio.org/portal/index.php?search=San+Pietro&category=l&client=pubmed&startPage=8>8</a></td><td align=center><a href=http://ubio.org/portal/index.php?search=San+Pietro&category=l&client=pubmed&startPage=9>9</a></td><td align=center><a href=http://ubio.org/portal/index.php?search=San+Pietro&category=l&client=pubmed&startPage=10>10</a></td><td align=center><a href=http://ubio.org/portal/index.php?search=San+Pietro&category=l&client=pubmed&startPage=2>¬Ľ</a></td></tr></table></table></tr></table></td><script src="http://www.google-analytics.com/urchin.js" type="text/javascript"> </script> <script type="text/javascript"> _uacct = "UA-634822-1"; urchinTracker(); </script> </BODY> </HTML>